Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Inventory: 2022-2024

Historic Change in Inventory for Whitehawk Therapeutics (WHWK) over the last 3 years, with Dec 2024 value amounting to -$1.1 million.

  • Whitehawk Therapeutics' Change in Inventory rose 65.31% to -$170,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$796,000, marking a year-over-year decrease of 195.56%. This contributed to the annual value of -$1.1 million for FY2024, which is 134.18% down from last year.
  • As of FY2024, Whitehawk Therapeutics' Change in Inventory stood at -$1.1 million, which was down 134.18% from $3.3 million recorded in FY2023.
  • Whitehawk Therapeutics' 5-year Change in Inventory high stood at $3.3 million for FY2023, and its period low was -$1.1 million during FY2024.
  • Over the past 3 years, Whitehawk Therapeutics' median Change in Inventory value was $1.9 million (recorded in 2022), while the average stood at $1.3 million.
  • Per our database at Business Quant, Whitehawk Therapeutics' Change in Inventory surged by 75.44% in 2023 and then tumbled by 134.18% in 2024.
  • Over the past 3 years, Whitehawk Therapeutics' Change in Inventory (Yearly) stood at $1.9 million in 2022, then soared by 75.44% to $3.3 million in 2023, then crashed by 134.18% to -$1.1 million in 2024.